Mrs. Mckenzie Russell Burns, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 414 Bozeman Rd, Madison, MS 39110 Phone: 601-914-9200 |
Dr. Margaux Antoine Nelms, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 138 Park Place Blvd, Madison, MS 39110 Phone: 601-982-0611 |
Kasi Cassandra Saucier Audiologist Medicare: Accepting Medicare Assignments Practice Location: 401 Baptist Dr Ste 206, Madison, MS 39110 Phone: 601-973-1583 Fax: 601-973-1609 |
Tiffany B Langham Audiologist Medicare: Not Enrolled in Medicare Practice Location: 401 Baptist Dr Ste 204, Madison, MS 39110 Phone: 601-973-1583 Fax: 601-973-1609 |
Carrie Tilley Snyder, AU.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 204 Key Dr Ste A, Madison, MS 39110 Phone: 601-351-5433 Fax: 601-779-9155 |
Katie Berry, AUD., CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 401 Baptist Dr Ste 206, Madison, MS 39110 Phone: 601-973-1583 Fax: 601-973-1681 |
Mrs. Mary Rebecca Foster, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 132 Bridge Water Drive, Madison, MS 39110 Phone: 601-898-0182 |
Dr. Anna Victoria Scarbrough, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 204 Key Dr Ste C, Madison, MS 39110 Phone: 601-351-5433 |
News Archive
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, today announced that it has entered into an oncology research collaboration and licensing agreement with MedImmune, the global biologics research and development arm of AstraZeneca. Both companies will research and develop novel cancer therapies using Immunocore's Immune Mobilising Monoclonal T-Cell Receptor Against Cancer technology.
By studying a little-known yeast too primitive to get diseases, Johns Hopkins researchers have uncovered a surprising link between two processes at play in heart disease and cancer in people.
St. Jude Children's Research Hospital scientists have discovered that a protein used by cancer cells to evade death also plays a vital role in heart health. This dual role complicates efforts to develop cancer drugs that target the protein, but may lead to new therapies for heart muscle damage. The research appeared in the June 15 edition of the scientific journal Genes & Development.
Coastal Contacts Inc. today announced its financial results for the second fiscal quarter, period ended April 30, 2010.
Berinert®, a human C1 esterase inhibitor (C1-INH) for treating acute episodes of facial or abdominal hereditary angioedema (HAE) in adults and adolescents has obtained approval from the US Food and Drug Administration (FDA).
› Verified 5 days ago